EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S152
DOI: 10.1055/s-0044-1783020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von K. Kozlowska-Petriczko und 5 weiteren Autor:innen. Die Arbeit nennt 1 Literaturangaben.
Abstract (Originalsprache)
Aims Insulinomas are the most frequent functional pancreatic neuroendocrine tumors (pNETs). While surgical resection remains still the gold standard treatment, endoscopic ultrasound (EUS)-guided ablation using either ethanol (EUS-EA) or radiofrequency (EUS-RFA) is a minimally invasive alternative treatment modality which induces lesion necrosis [ 1 ]. This study presents a single-center experience in treating pancreatic insulinomas
Zitieren
APA
Kozlowska-Petriczko, K., Pawlak, K. M., Kozlowska, K., Jedruszek, S., Bosy-Gasior, W., & Wiechowska-Kozłowska, A. (2024). EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience. Endoscopy, 56(S 02 S 02), S152. https://doi.org/10.1055/s-0044-1783020
Vancouver
Kozlowska-Petriczko K, Pawlak KM, Kozlowska K, Jedruszek S, Bosy-Gasior W, Wiechowska-Kozłowska A. EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience. Endoscopy. 2024;56(S 02 S 02):S152. doi:10.1055/s-0044-1783020
BibTeX
@article{KozlowskaPetriczko2024,
author = {Kozlowska-Petriczko, K. and Pawlak, K. M. and Kozlowska, K. and Jedruszek, S. and Bosy-Gasior, W. and Wiechowska-Kozłowska, A.},
title = {EUS-guided radiofrequency and ethanol ablation of pancreatic insulinomas: a single-center experience},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S152},
doi = {10.1055/s-0044-1783020}
}
EUVIMED